Prophylaxis and treatment of COVID-19 using a nasal spray containing 3% dimethyl sulfoxide (DMSO) and 20% ethanol solution (2020)

Peer-Reviewed Study · Shahroud University of Medical Sciences · September 13, 2020

Shahroud University of Medical Sciences, 2020-09-13: Iranian phase 3 triple-blind randomized trial of a nasal spray containing 3% DMSO and 20% ethanol for COVID-19 prophylaxis and treatment; record lists recruiting, no results.

Prophylaxis and treatment of COVID-19 using a nasal spray containing 3% dimethyl sulfoxide (DMSO) and 20% ethanol solution

Shahroud University of Medical Sciences, 2020-09-13: Iranian phase 3 triple-blind randomized trial of a nasal spray containing 3% DMSO and 20% ethanol for COVID-19 prophylaxis and treatment; record lists recruiting, no results. IRCT20200727048217N1; Iran (Islamic Republic of); COVID-19 prophylaxis and treatment; sponsor Shahroud University of Medical Sciences; phase 3; target sample 610; status Recruiting (per ICTRP record); results: not available. DMSO 3% with 20% ethanol as nasal spray versus placebo; randomized, triple-blind, parallel; interventional. Funder: Shahroud University of Medical Sciences. Conflicts: not stated. Also filed as DML-68 (claims C9). Study type: randomized trial.